Bellicum Pharmaceuticals, Inc. Debt to Equity Ratio 2015-2023 | BLCM
Current and historical debt to equity ratio values for Bellicum Pharmaceuticals, Inc. (BLCM) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Bellicum Pharmaceuticals, Inc. debt/equity for the three months ending September 30, 2023 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2023-09-30 | $0.00B | $0.01B | 0.49 |
| 2023-06-30 | $0.00B | $0.01B | 0.66 |
| 2023-03-31 | $0.01B | $0.01B | 0.38 |
| 2022-12-31 | $0.00B | $0.02B | 0.19 |
| 2022-09-30 | $0.01B | $0.03B | 0.23 |
| 2022-06-30 | $0.01B | $0.03B | 0.14 |
| 2022-03-31 | $0.01B | $0.04B | 0.23 |
| 2021-12-31 | $0.01B | $0.04B | 0.16 |
| 2021-09-30 | $0.02B | $0.01B | 2.81 |
| 2021-06-30 | $0.02B | $0.00B | 5.31 |
| 2021-03-31 | $0.03B | $0.01B | 5.09 |
| 2020-12-31 | $0.03B | $0.02B | 1.61 |
| 2020-09-30 | $0.09B | $-0.03B | -3.26 |
| 2020-06-30 | $0.10B | $-0.03B | -3.64 |
| 2020-03-31 | $0.08B | $0.01B | 5.90 |
| 2019-12-31 | $0.12B | $-0.01B | -25.48 |
| 2019-09-30 | $0.11B | $0.02B | 4.87 |
| 2019-06-30 | $0.06B | $0.03B | 1.96 |
| 2019-03-31 | $0.06B | $0.05B | 1.13 |
| 2018-12-31 | $0.05B | $0.07B | 0.77 |
| 2018-09-30 | $0.05B | $0.09B | 0.56 |
| 2018-06-30 | $0.05B | $0.11B | 0.44 |
| 2018-03-31 | $0.05B | $0.07B | 0.76 |
| 2017-12-31 | $0.05B | $0.09B | 0.60 |
| 2017-09-30 | $0.05B | $0.10B | 0.43 |
| 2017-06-30 | $0.05B | $0.12B | 0.37 |
| 2017-03-31 | $0.05B | $0.14B | 0.32 |
| 2016-12-31 | $0.04B | $0.10B | 0.37 |
| 2016-09-30 | $0.03B | $0.11B | 0.26 |
| 2016-06-30 | $0.02B | $0.13B | 0.18 |
| 2016-03-31 | $0.02B | $0.14B | 0.17 |
| 2015-12-31 | $0.01B | $0.15B | 0.06 |
| 2015-09-30 | $0.01B | $0.17B | 0.04 |
| 2015-06-30 | $0.00B | $0.18B | 0.02 |
| 2015-03-31 | $0.00B | $0.19B | 0.02 |
| 2014-12-31 | $0.00B | $0.19B | 0.02 |
| 2014-09-30 | $0.00B | 0.00 | |
| 2014-06-30 | $0.00B | 0.00 | |
| 2014-03-31 | $0.00B | 0.00 | |
